Skip to main content

Biopharma Startups

Updated November 2026

Companies in the biopharma sector developing innovative solutions and technologies.

Explore 915 recently funded biopharma companies with verified founder contact information and fundraising data.

Total Companies
915
Total Funding
$883.3M
Avg Funding
$35.3M
Global Reach
7
countries

Top Cities for Biopharma

Princeton
Södertälje
South San Francisco
San Diego
New York
Boston

Recently Funded Companies

Export
Princeton, United States

4M Therapeutics Inc. (4MTx) develops therapies for central nervous system (CNS) disorders with blockbuster potential.

Aug 2025

Founder Contacts

41,000+ verified contacts

Södertälje, Sweden

Anocca is a clinical-stage biopharmaceutical company that develops T-cell receptors to treat infectious and autoimmune diseases.

$46.1M raised
Aug 2025

Founder Contacts

41,000+ verified contacts

South San Francisco, United States

CellChorus applies visual AI to evaluate how individual cells move, behave, and interact.

$200K raised
Aug 2025

Founder Contacts

41,000+ verified contacts

San Diego, United States

SRT Therapeutics is a Biotechnology Research oriented firm currently working in stealth mode.

$47.4M raised
Aug 2025

Founder Contacts

41,000+ verified contacts

New York, United States

Gameto is a biotechnology company developing therapeutics of the female reproductive system using cell engineering.

$44.0M raised
Aug 2025

Founder Contacts

41,000+ verified contacts

Boston, United States

Compass Therapeutics is a biopharmaceutical company that focuses on drugging the immune system to treat human diseases.

$120.0M raised
Aug 2025

Founder Contacts

41,000+ verified contacts

Northbrook, United States

Jocasta Neuroscience is a biotech company that offers healthcare services.

$35.0M raised
Aug 2025

Founder Contacts

41,000+ verified contacts

Berkeley, United States

Nanotein Technologies is a biotechnology company that develops drugs for immunotherapy.

$3.0M raised
Aug 2025

Founder Contacts

41,000+ verified contacts

Vienna, United States

Enhanced Fusion Technologies is a biotechnology company.

$480K raised
Aug 2025

Founder Contacts

41,000+ verified contacts

Seattle, United States

Oisin Biotechnologies is a drug development company focused on mitigating the senolytic technology to combat age-related diseases.

$10.0M raised
Aug 2025

Founder Contacts

41,000+ verified contacts

Cincinnati, United States

Eikonoklastes is rapidly advancing innovative medicines for numerous areas of significant unmet medical need.

$13.6M raised
Jul 2025

Founder Contacts

41,000+ verified contacts

Palo Alto, United States

Juvena Therapeutics is a biopharmaceutical platform which is discovering novel protein-based therapeutics.

$30.5M raised
Jul 2025

Founder Contacts

41,000+ verified contacts

Franklin, United States

Adora Life Science is a Biotechnology firm developing and researching on pharmaceutical related to inflammation, diabetes and regeneration.

$1.0M raised
Jul 2025

Founder Contacts

41,000+ verified contacts

Seattle, United States

Avalyn Pharma is a biopharma company developing therapies for the treatment of idiopathic pulmonary fibrosis and other respiratory diseases.

$100.0M raised
Jul 2025

Founder Contacts

41,000+ verified contacts

Conshohocken, United States

Madrigal Pharmaceuticals is a biopharmaceutical company developing therapeutics for the treatment of cardiovascular-metabolic diseases.

$350.0M raised
Jul 2025

Founder Contacts

41,000+ verified contacts

Geneva, Switzerland

Azure Cell Therapies is a biotech company developing next-gen CGTs for neurodegenerative diseases

$189K raised
Jul 2025

Founder Contacts

41,000+ verified contacts

Rosario, Argentina

Exomas develops exosome-based products that expand the cognitive reserve and induce neuronal plasticity to treat neurodegenerative diseases.

$31K raised
Jul 2025

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Sequome is a biotechnology company that offers a platform to decodes designs sequences for the development of sequence medicines.

$10.6M raised
Jul 2025

Founder Contacts

41,000+ verified contacts

Mcallen, United States

Sur180 Therapeutics is a female-led business that focuses on novel ways to treating gynecological diseases.

$2.4M raised
Jul 2025

Founder Contacts

41,000+ verified contacts

Bordeaux, France

bYoRNA is cost-efficient, scalable bioproduction of high-quality therapeutic mRNA using eukaryotic cells, particularly recombinant yeast.

$1.8M raised
Jul 2025

Founder Contacts

41,000+ verified contacts

Saint-antoine, France

BrainEver is a operator of a medical research agency intended to offer drugs for the treatment of neurodegenerative disorders.

$38.9M raised
Jul 2025

Founder Contacts

41,000+ verified contacts

Napoli, Italy

FTnet connects the Pharmaceutical Industry and Pharmacy through multi-sided technology.

$4.7M raised
Jul 2025

Founder Contacts

41,000+ verified contacts

Cambridge, United Kingdom

Healx is a rare disease biotechnology company that uses generative AI for drug discovery.

Jul 2025

Founder Contacts

41,000+ verified contacts

Woburn, United States

Biofrontera is a biopharmaceutical company specializing in photodynamic therapy and topical antibiotics.

$8.5M raised
Jun 2025

Founder Contacts

41,000+ verified contacts

Orange, United States

DIMERx operates as a biopharmaceutical company.

$15.0M raised
Jun 2025

Founder Contacts

41,000+ verified contacts

Showing 326 to 350 of 915 companies

About the Biopharma Startup Ecosystem

The biopharma sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Biopharma

Biopharma companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The biopharma sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Biopharma Funding Breakdown

Here is how funding is distributed among the 915 biopharma companies tracked in the VCBacked database.

Average Funding
$35.3M
Total Funding Tracked
$883.3M
Countries Represented
7

Distribution by Funding Stage

Other25 companies

Top Cities for Biopharma

1.Seattle
2 companies$110.0M
2.Princeton
1 companiesUndisclosed
3.Södertälje
1 companies$46.1M
4.South San Francisco
1 companies$200K
5.San Diego
1 companies$47.4M

Related Industries

Companies in the biopharma sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Biopharma Startups?

Perfect for: B2B sales teams targeting biopharma companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

915 Biopharma Startups (2026) — Recently Funded — Page 14 | VCBacked